This capsule combines enteric-coated Rabeprazole Sodium with sustained-release Domperidone, formulated for the management of acid-related gastrointestinal conditions accompanied by motility disturbances.

Each unit of this proton pump inhibitor prokinetic combination capsule contains Rabeprazole Sodium IP 20 mg (enteric coated) + Domperidone IP 30 mg (sustained release), formulated in capsules form and manufactured in compliance with Indian Pharmacopoeia (IP) standards. This ensures uniform potency and quality across every production batch, a key requirement for pharmaceutical importers and distributors evaluating acid reflux gastric motility medication for their regional markets.

Indicated for management of acid-peptic disorders with associated gastric motility issues, under physician guidance. Suitable for pharmacy, clinic, and hospital supply.

Packed in 10x10 blister strips to protect the enteric coating and sustained-release properties during export. The 10x10 Capsules configuration is widely used in international pharmaceutical trade, supporting efficient inventory management for wholesalers and institutional buyers sourcing enteric-coated gastrointestinal formulation in bulk quantities.

CD&M Remedies is an established manufacturer of IP-compliant pharmaceutical formulations, supplying proton pump inhibitor prokinetic combination capsule to B2B buyers and importers worldwide. Buyers benefit from consistent formulation quality, reliable supply capability, and export-oriented packing suited to cross-border pharmaceutical trade.

Q: What is the composition of Rabeprazole Sodium And Domperidone Sustained Release Capsules Crab-Dsr?
A: It contains Rabeprazole Sodium IP 20 mg (enteric coated) + Domperidone IP 30 mg (sustained release), manufactured to Indian Pharmacopoeia (IP) standards in capsules form.

Q: What pack sizes are available for Rabeprazole Sodium And Domperidone Sustained Release Capsules Crab-Dsr?
A: This product is supplied in 10x10 Capsules export packing, suitable for wholesale and institutional bulk orders.

Q: Who manufactures Rabeprazole Sodium And Domperidone Sustained Release Capsules Crab-Dsr?
A: Rabeprazole Sodium And Domperidone Sustained Release Capsules Crab-Dsr is manufactured and supplied by CD&M Remedies, under product code 1016.

Q: Which product category does Rabeprazole Sodium And Domperidone Sustained Release Capsules Crab-Dsr belong to?
A: It falls under the Gastrointestinal Medication (PPI + Prokinetic Combination) category, intended for B2B pharmaceutical buyers and importers.